| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 5 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | Canada | 4 | |
| #4 | Taiwan | 4 | |
| #5 | WIPO (World Intellectual Property Organization) | 4 | |
| #6 | Japan | 3 | |
| #7 | Republic of Korea | 3 | |
| #8 | Norway | 3 | |
| #9 | China | 2 | |
| #10 | Israel | 2 | |
| #11 | Mexico | 2 | |
| #12 | Brazil | 1 | |
| #13 | United Kingdom | 1 | |
| #14 | New Zealand | 1 | |
| #15 | Ukraine | 1 | |
| #16 | United States | 1 | |
| #17 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Measurement | |
| #4 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Sugars | |
| #4 | Steroids | |
| #5 | Analysing materials | |
| #6 | Heterocyclic compounds | |
| #7 | Peptides | |
| #8 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Myhren Finn | 35 |
| #2 | Eriksen Ole Henrik | 24 |
| #3 | Sandvold Marit Liland | 23 |
| #4 | Ahrabi Sayeh | 13 |
| #5 | Hagen Steinar | 10 |
| #6 | Cass Carol E | 5 |
| #7 | Young James D | 5 |
| #8 | Finn Myhren | 3 |
| #9 | Silverman Lewis | 2 |
| #10 | Jacobsen Tove Flem | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2012142411A1 | Systems and methods for detecting hent1 expression in hematological disorders | |
| KR20130142994A | Parenteral formulations of elacytarabine derivatives | |
| TW201211251A | Anti-human equilibrative nucleoside transporter 1 (hENT1) antibodies and methods of use thereof | |
| AU2011266705A1 | Anti-human equilibrative nucleoside transporter 1 (hENT1) antibodies and methods of use thereof | |
| WO2011121453A2 | Methods and compositions for treating or ameliorating cancer using gemcitabine-5'-elaidate | |
| CA2778432A1 | Parenteral formulations of gemcitabine derivatives | |
| KR20090123961A | Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |